BERLIN, April 28 (Reuters) - BioNTech expects that the COVID-19 vaccine it is making with Pfizer will win approval from the Chinese health authorities “by June at the latest”, Chief Executive Ugur Sahin said on Wednesday.This would mean that it would be possible to distribute the vaccine in China from July, the founder of the biotech startup told an online briefing with the German foreign correspondents’ association.“I am optimistic that we can help the people of China,” said Sahin, adding that local partner Shanghai Fosun Pharmaceutical Group Co Ltd was “a great company”. (Reporting by Douglas Busvine, editing by Kirsti Knolle)机器翻译：生物科技首席执行官Ugur Sahin周三表示，该公司预计，与辉瑞(Pfizer)合作生产的COVID-19疫苗最迟将于6月获得中国卫生当局的批准。这位生物技术初创企业的创始人在德国外国通
………………………………
